First MHRA-approved low-dose atropine eye drop to slow the progression of myopia (short-sightedness) in children aged 3-14 years with a progression rate of 0.5 D or more per year and a severity of -0.

McConnell’s hemp ban risks wiping out most U.S. hemp-derived products, while MSOs pin hopes on Schedule III rescheduling that ...

In today’s technology-driven world, gadgets have become an inseparable part of daily life. From smartphones and tablets to ...

When you look at the promotional materials advertising luxury high-rise developments in London, it is obvious that the ...

OWEN MCDONNELL: Hello Gophers and Gopher adjacents, my name is Owen McDonnell and welcome to yet another episode of In The Know, a podcast dedicated to the University of Minnesota. As you probably ...